In Depth 24 Jan 2025
Why are there only 20 cell and gene therapies in Europe?
There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem.
In Depth
- Latest Posts
In Depth 23 Jan 2025
mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics
In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases.
In Depth 20 Jan 2025
Is biotech M&A set to surge in 2025?
There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play.
In Depth 17 Jan 2025
Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?
In Depth 15 Jan 2025
CRISPR: The gene editing tool changing the world (2025 update)
CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential?
In Depth 13 Jan 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.
ADVERTISEMENT
ADVERTISEMENT
In Depth 9 Jan 2025
Saudi Arabia: is the country set to become a global biotech hub?
In the last year or so, there have been a number of indications that Saudi Arabia is setting itself up to become a global biotech hub. Over the next decade, it is expected to become a world leader in biotech research and generate significant economic growth. The most recent indication of Saudi Arabia’s progress toward […]
In Depth 7 Jan 2025
The biggest private biotech investments in December 2024
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.
In Depth 25 Dec 2024
When biotech makes Christmas miracles a reality
Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.
In Depth 19 Dec 2024
After decades of stagnation, is Japan’s biopharma industry set for an upswing?
Discover the history of Japan’s biopharma industry and whether it is now set for an upswing after years of stagnation from economic troubles.
In Depth 18 Dec 2024
AI + CRISPR: The explosive fusion that will redefine biotechnology
With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration.
In Depth 17 Dec 2024
Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic
A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding.
ADVERTISEMENT
